These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 20090761

  • 1. Testosterone, SHBG and cardiovascular health in postmenopausal women.
    Brand JS, van der Schouw YT.
    Int J Impot Res; 2010; 22(2):91-104. PubMed ID: 20090761
    [Abstract] [Full Text] [Related]

  • 2. Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women.
    Maturana MA, Breda V, Lhullier F, Spritzer PM.
    Metabolism; 2008 Jul; 57(7):961-5. PubMed ID: 18555838
    [Abstract] [Full Text] [Related]

  • 3. Sex hormone levels and risk of cardiovascular events in postmenopausal women.
    Rexrode KM, Manson JE, Lee IM, Ridker PM, Sluss PM, Cook NR, Buring JE.
    Circulation; 2003 Oct 07; 108(14):1688-93. PubMed ID: 12975257
    [Abstract] [Full Text] [Related]

  • 4. Sex hormone-binding globulin and serum testosterone are inversely associated with C-reactive protein levels in postmenopausal women at high risk for cardiovascular disease.
    Joffe HV, Ridker PM, Manson JE, Cook NR, Buring JE, Rexrode KM.
    Ann Epidemiol; 2006 Feb 07; 16(2):105-12. PubMed ID: 16216530
    [Abstract] [Full Text] [Related]

  • 5. Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study.
    Undén AL, Elofsson S, Brismar K.
    Clin Endocrinol (Oxf); 2005 Jul 07; 63(1):94-102. PubMed ID: 15963068
    [Abstract] [Full Text] [Related]

  • 6. Lipid accumulation product (LAP) is related to androgenicity and cardiovascular risk factors in postmenopausal women.
    Maturana MA, Moreira RM, Spritzer PM.
    Maturitas; 2011 Dec 07; 70(4):395-9. PubMed ID: 22018728
    [Abstract] [Full Text] [Related]

  • 7. Endogenous androgen levels and cardiovascular risk profile in women across the adult life span.
    Bell RJ, Davison SL, Papalia MA, McKenzie DP, Davis SR.
    Menopause; 2007 Dec 07; 14(4):630-8. PubMed ID: 17224854
    [Abstract] [Full Text] [Related]

  • 8. Does androgen excess contribute to the cardiovascular risk profile in postmenopausal women with type 2 diabetes?
    Korytkowski MT, Krug EI, Daly MA, Deriso L, Wilson JW, Winters SJ.
    Metabolism; 2005 Dec 07; 54(12):1626-31. PubMed ID: 16311096
    [Abstract] [Full Text] [Related]

  • 9. Androgens in relationship to cardiovascular risk factors in the menopausal transition.
    Mesch VR, Siseles NO, Maidana PN, Boero LE, Sayegh F, Prada M, Royer M, Schreier L, Benencia HJ, Berg GA.
    Climacteric; 2008 Dec 07; 11(6):509-17. PubMed ID: 18991078
    [Abstract] [Full Text] [Related]

  • 10. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group.
    Pasquali R, Vicennati V, Bertazzo D, Casimirri F, Pascal G, Tortelli O, Labate AM.
    Metabolism; 1997 Jan 07; 46(1):5-9. PubMed ID: 9005961
    [Abstract] [Full Text] [Related]

  • 11. C-peptide, IGF-I, sex-steroid hormones and adiposity: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Bezemer ID, Rinaldi S, Dossus L, Gils CH, Peeters PH, Noord PA, Bueno-de-Mesquita HB, Johnsen SP, Overvad K, Olsen A, Tjønneland A, Boeing H, Lahmann PH, Linseisen J, Nagel G, Allen N, Roddam A, Bingham S, Khaw KT, Kesse E, Téhard B, Clavel-Chapelon F, Agudo A, Ardanaz E, Quiros JR, Amiano P, Martínez-Garcia C, Tormo MJ, Pala V, Panico S, Vineis P, Palli D, Tumino R, Trichopoulou A, Baibas N, Zilis D, Hémon B, Norat T, Riboli E, Kaaks R.
    Cancer Causes Control; 2005 Jun 07; 16(5):561-72. PubMed ID: 15986111
    [Abstract] [Full Text] [Related]

  • 12. Obesity and menstrual irregularity: associations with SHBG, testosterone, and insulin.
    Wei S, Schmidt MD, Dwyer T, Norman RJ, Venn AJ.
    Obesity (Silver Spring); 2009 May 07; 17(5):1070-6. PubMed ID: 19180069
    [Abstract] [Full Text] [Related]

  • 13. Adipocytokines, sex hormones, and cardiovascular risk factors in postmenopausal women: factor analysis of the Rancho Bernardo study.
    Krentz AJ, von Mühlen D, Barrett-Connor E.
    Horm Metab Res; 2009 Oct 07; 41(10):773-7. PubMed ID: 19499502
    [Abstract] [Full Text] [Related]

  • 14. Sex steroid hormones, sex hormone-binding globulin, and obesity in men and women.
    Tchernof A, Després JP.
    Horm Metab Res; 2000 Oct 07; 32(11-12):526-36. PubMed ID: 11246820
    [Abstract] [Full Text] [Related]

  • 15. Endogenous sex hormones and C-reactive protein in healthy postmenopausal women.
    Störk S, Bots ML, Grobbee DE, van der Schouw YT.
    J Intern Med; 2008 Sep 07; 264(3):245-53. PubMed ID: 18341528
    [Abstract] [Full Text] [Related]

  • 16. Associations among sex hormone binding globulin concentrations and characteristics of the metabolic syndrome in obese women.
    Cikim AS, Ozbey N, Sencer E, Molvalilar S, Orhan Y.
    Diabetes Nutr Metab; 2004 Oct 07; 17(5):290-5. PubMed ID: 16295051
    [Abstract] [Full Text] [Related]

  • 17. Is there an independent association between waist-to-hip ratio and cardiovascular risk factors in overweight and obese women?
    Azizi F, Esmaillzadeh A, Mirmiran P, Ainy E.
    Int J Cardiol; 2005 May 11; 101(1):39-46. PubMed ID: 15860381
    [Abstract] [Full Text] [Related]

  • 18. The effect of intrauterine and oral levonorgestrel administration on serum concentrations of sex hormone-binding globulin, insulin and insulin-like growth factor binding protein-1.
    Pakarinen P, Lähteenmäki P, Rutanen EM.
    Acta Obstet Gynecol Scand; 1999 May 11; 78(5):423-8. PubMed ID: 10326889
    [Abstract] [Full Text] [Related]

  • 19. Sex hormone binding globulin gene polymorphisms and metabolic syndrome in postmenopausal Turkish women.
    Sunbul M, Eren F, Nacar C, Agirbasli M.
    Cardiol J; 2013 May 11; 20(3):287-93. PubMed ID: 23788303
    [Abstract] [Full Text] [Related]

  • 20. Effect of postmenopause and hormone replacement therapy on serum adiponectin levels.
    Sieminska L, Wojciechowska C, Niedziolka D, Marek B, Kos-Kudla B, Kajdaniuk D, Nowak M.
    Metabolism; 2005 Dec 11; 54(12):1610-4. PubMed ID: 16311093
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.